Stockscreener 앱 받기
31.00
0.32%
0.10
전일 마감가:
$30.90
열려 있는:
$31.06
하루 거래량:
417.53K
Relative Volume:
0.82
시가총액:
$1.68B
수익:
$2.22M
순이익/손실:
$-40.51M
주가수익비율:
-24.13
EPS:
-1.2847
순현금흐름:
$-46.53M
1주 성능:
+4.20%
1개월 성능:
+5.73%
6개월 성능:
+183.88%
1년 성능:
+184.93%
1일 변동 폭
$29.80
$31.64
1주일 범위
$29.34
$33.68
52주 변동 폭
$5.14
$33.68
Upstream Bio Inc Stock (UPB) Company Profile
명칭
Upstream Bio Inc
전화
781-208-2466
주소
890 WINTER STREET, SUITE 200, WALTHAM
UPB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
31.00 | 1.67B | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-18 | 개시 | Mizuho | Outperform |
| 2025-11-18 | 개시 | Evercore ISI | Outperform |
| 2025-10-14 | 개시 | Truist | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | Piper Sandler | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Upstream Bio Inc 주식(UPB)의 최신 뉴스
Sectors Review: Is Upstream Bio Inc a cyclical or defensive stockTake Profit & Community Verified Trade Alerts - baoquankhu1.vn
Why Upstream Bio (UPB) Is Up 12.2% After JPM Debut And VALINAT Hopes - simplywall.st
Can Upstream Bio Inc outperform in the next rallyWeekly Trading Summary & Long-Term Growth Stock Strategies - baoquankhu1.vn
Upstream Bio stock hits all-time high at 33.05 USD By Investing.com - Investing.com Nigeria
Aug Volume: Is Upstream Bio Inc a defensive stockMarket Risk Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Upstream Bio (NASDAQ:UPB) Reaches New 52-Week HighHere's What Happened - MarketBeat
US Market Recap: Can Upstream Bio Inc ride the EV wave2025 Price Action Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Positioning Upstream Bio for Commercial Success: Buy Rating on UPB Driven by Physician Enthusiasm and Long-Acting TSLP Opportunity Ahead of VALINAT Readout - TipRanks
Upstream Bio, Inc. (NASDAQ:UPB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Upstream Bio, Inc. (NASDAQ:UPB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Upstream Bio’s Verekitug Study: A Potential Game-Changer for Severe Asthma Treatment - MSN
Fed Watch: Is Upstream Bio Inc stock a bargain at current levelsJuly 2025 Final Week & Weekly Hot Stock Watchlists - Bộ Nội Vụ
Is Upstream Bio Inc. stock vulnerable to regulatory risks2025 Technical Patterns & Weekly Top Gainers Alerts - Улправда
How Upstream Bio Inc. stock reacts to Fed rate cutsMarket Growth Report & Free Community Consensus Stock Picks - Улправда
Will Upstream Bio Inc. stock maintain dividend yield2025 Trading Recap & Weekly Stock Breakout Alerts - Улправда
Is Upstream Bio Inc. stock a bargain at current levelsMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Upstream Bio: Fully Priced After Recent Rally (NASDAQ:UPB) - Seeking Alpha
How Invesco Quality Municipal Income Trust stock performs after earningsMarket Sentiment Review & Technical Buy Zone Confirmations - Улправда
Is National Vision Holdings Inc. stock positioned for long term growthTrade Exit Summary & Daily Price Action Insights - Улправда
Upstream Bio (NASDAQ:UPB) Trading 7.8% HigherTime to Buy? - MarketBeat
Will Upstream Bio Inc. stock rally after Fed decisionsTrading Volume Surges & Free High Yield Market Plays - Улправда
Upstream Bio initiated with an Outperform at LifeSci Capital - MSN
Upstream Bio (NASDAQ:UPB) Stock Price Down 6.2%What's Next? - MarketBeat
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Upstream Bio Inc Stock Price ($UPB), Quote & News - eToro
Upstream Bio initiated with an outperform at Mizuho - MSN
AI Indicators Detect Buy Opportunity in Zenith Drugs LimitedCash Flow Trends & Outstanding Investment Returns - earlytimes.in
Geopolitics Watch: How Upstream Bio Inc stock reacts to Fed rate cutsWeekly Market Report & Fast Momentum Entry Tips - moha.gov.vn
Upstream Bio (NASDAQ:UPB) Shares Down 3.4%Time to Sell? - MarketBeat
Treasury Yields: How Upstream Bio Inc stock reacts to global recession fearsBuy Signal & Reliable Breakout Forecasts - moha.gov.vn
Upstream Bio Reports Progress in Respiratory Trials - MSN
Upstream Bio (NASDAQ:UPB) Stock Price Up 4.8%Should You Buy? - MarketBeat
Upstream Bio (UPB) price target decreased by 18.03% to 51.00 - MSN
Upstream Bio (UPB): NASDAQ Biotech Index Entry Sparks the Big Rerating Debate - parameter.io
Upstream Bio, Inc.(NasdaqGS: UPB) added to NASDAQ Biotechnology Index - marketscreener.com
Upstream Bio, Inc. (UPB) Eps Diluted (Quarterly) - Zacks Investment Research
Upstream Bio, Inc. (NASDAQ:UPB) Receives $45.25 Average Price Target from Brokerages - Defense World
Can Upstream Bio Inc. stock weather global recessionPortfolio Risk Report & Accurate Entry and Exit Point Alerts - Улправда
Why retail investors favor Upstream Bio Inc. stockWeekly Risk Summary & Low Volatility Stock Suggestions - Улправда
Does Mizuho’s New Coverage of Upstream Bio (UPB) Reframe the Stock’s Risk‑Reward Narrative? - Sahm
How Upstream Bio Inc. stock reacts to global recession fearsNew Guidance & Risk Controlled Swing Alerts - DonanımHaber
Will Upstream Bio Inc. stock beat EPS estimatesEarnings Growth Summary & Risk Adjusted Swing Trade Ideas - Улправда
Upstream Bio (NASDAQ:UPB) Stock Rating Upgraded by Mizuho - MarketBeat
Would You Still Hold Upstream Bio Stock If It Fell 30%? - Trefis
Is Upstream Bio Inc. stock overvalued by current metricsTrade Analysis Summary & Weekly Sector Rotation Insights - Улправда
How Upstream Bio Inc. stock reacts to inflationary pressures2025 Sector Review & Risk Managed Investment Strategies - DonanımHaber
Will Upstream Bio Inc. stock benefit from green energy trends2025 Top Gainers & Expert-Curated Trade Recommendations - Улправда
Chipmakers Recap: Can Upstream Bio Inc. stock weather global recessionJuly 2025 Levels & Low Risk Investment Opportunities - Улправда
Upstream Bio, Inc. (NASDAQ:UPB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Mizuho Initiates Coverage on UPB with Outperform Rating and $51 PT | UPB Stock News - GuruFocus
Mizuho initiates Upstream Bio stock with Outperform rating on asthma drug potential - Investing.com Canada
Upstream Bio Inc (UPB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):